A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Dec 2018
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Acronyms CONSTANT
- Sponsors VBI Vaccines
- 09 Nov 2018 Status changed from recruiting to active, no longer recruiting, according to a VBI Vaccines media release.
- 09 Nov 2018 According to a VBI Vaccines media release, the last subject received the first vaccination in November 2018 in this trial.
- 26 Jul 2018 According to a VBI Vaccines media release, topline data from this trial is expected in the second half of 2019.